In clinical psychiatry one soon learns to look for patcontinue to grow as the full integration of molecular medicine and clinical psychiatry moves forward.
5 terns that repeat themselves over time because they reveal important themes. As we start our second volPlease advise: ϽlicinioȰnih.govϾ. Molecular biology offers much that is exciting for us ume we can start to identify themes that are emerging within molecular psychiatry. These include genetics, in psychiatry. Using the tools of molecular medicine it is now possible to rapidly move from bench to bedside molecular neurobiology, histological methods applied to brain tissue, imaging, and the very recent advances and back in molecular psychiatry. Psychiatric disorders are characterized by disordered function of the in the molecular neurobiology of Alzheimer's disease. Within these broad themes, there are specific points central nervous system (CNS), resulting in many types of alterations, particularly the processing of inforthat deserve attention. In my view these include association studies, the issue of using postmortem tissue in mation. Signal processing is a key function of the brain: we can conceptualize molecular psychiatry as a field research studies, and whether recent progress in Alzheimer's disease will be soon paralleled by progress on that studies signaling, at the most fundamental intracellular level as well as at the extracellular level. Signal the fundamental biological mechanisms of other psychiatric disorders.
transduction is affected by the genome and by the environment. The end results of intra-and extracelluThe issues related to postmortem work and recent advances in research on Alzheimer's disease have been lar signaling are functions such as mood, cognition, and behavior. Conceptualizing molecular psychiatry as covered by recent articles in Molecular Psychiatry.
1-4
I will make a few personal comments on association a discipline that studies CNS functions that are affected by the processing of intra-and extracellular signals, we studies. Our field needs to come to a consensus on the meaning of statistically significant (or non-significant) can keep a focus as we repeatedly move between bench and bedside (see Figure 1 ). associations. Let's assume that 60% of individuals with a common, complex psychiatric disorder have a speThese are not original ideas. The integration of internal medicine and molecular biology started in the cific polymorphism in a gene that might be relevant to the disease, in contrast to an overall incidence of 35%
1980s. As that happened many investigators in fields such as molecular endocrinology questioned whether for that same polymorphism in the general population, with a P of Ͻ10 −5
. What is the value of such a finding?
prior approaches such as hormone measurements were still needed in clinical research. The conclusions of the Does it bring us closer to the cause of the disease in question? Does it tell us that a specific gene is indeed discussions that took place in the field of endocrinology are that organized signaling occurs at every level, involved in the pathophysiology of the disorder? Does it facilitate diagnosis? Does it influence treatment? from the microcosm where one structure interlocks with another at high affinity -affecting how long they What happens when other investigators, studying other populations, find different rates of incidence in are in a suitable conformation, to second messengers and phosphorylated proteins, and to regulated timing patients and controls for that specific polymorphism? The reverse is also an important point. What should in fairly complex feedback loops involving several chemical messengers interacting in the blood stream. one do when one paper reports lack of association between a specific gene and a disease? Should others Intra-and extra-cellular signaling are parts of a homeostatic network which is crucial for the optimal funccontinue to pursue that association? If a positive finding does come out, how does one integrate it with previous negative reports? Interestingly, some in this field seem to generate mostly negative data, while some others generate a fair amount of positive data. Is that related to personal differences in how one approaches research? These important questions deserve discussion because the number of association studies will endocrinology interfaced with clinical research in the 3 Dean B, Crook JM, Opeskin K, Hill C, Keks N, Copolov 1980s have led to refinements in clinical research stra-DL. The density of muscarinic M 1 receptors is decreased tegies that make it possible to examine how alterations in the caudate-putamen of subjects with schizophrenia.
in signaling at the clinical and molecular levels con- 
